Alastair Hamilton, CEO Invest Northern Ireland said: “Today’s announcement that multinational health technology company Philips is to purchase PathXL is great news for the life sciences sector in Northern Ireland. PathXL has been a fast growing business making a real name for itself specialising in software which improves the analysis of cancer tumours and has caught the attention of this global brand.
“We have had the opportunity to work with PathXL throughout its growth, with significant investments being made as part of our Access to Finance initiative. We have also helped the company invest in R&D.
“Today’s announcement is testament to the hard work and commitment of this business and recognition of its achievements. We wish it every success in the next stage of its growth as part of the Philips group.”